Literature DB >> 16864728

Neutralization of interleukin-18 inhibits neointimal formation in a rat model of vascular injury.

Pasquale Maffia1, Gianluca Grassia, Paola Di Meglio, Rosa Carnuccio, Liberato Berrino, Paul Garside, Angela Ianaro, Armando Ialenti.   

Abstract

BACKGROUND: Studies in humans and animal models suggest that interleukin-18 (IL-18) plays a crucial role in vascular pathologies. IL-18 is a predictor of cardiovascular death in angina and is involved in atherotic plaque destabilization. Higher IL-18 plasma levels also are associated with restenosis after coronary artery angioplasty performed in patients with acute myocardial infarction. We investigated the effective role of IL-18 in neointimal formation in a balloon-induced rat model of vascular injury. METHODS AND
RESULTS: Endothelial denudation of the left carotid artery was performed by use of a balloon embolectomy catheter. Increased expression of IL-18 and IL-18Ralpha/beta mRNA was detectable in carotid arteries from days 2 to 14 after angioplasty. The active form of IL-18 was highly expressed in injured arteries. Strong immunoreactivity for IL-18 was detected in the medial smooth muscle cells at days 2 and 7 after balloon injury and in proliferating/migrating smooth muscle cells in neointima at day 14. Moreover, serum concentrations of IL-18 were significantly higher among rats subjected to vascular injury. Treatment with neutralizing rabbit anti-rat IL-18 immunoglobulin G significantly reduced neointimal formation (by 27%; P < 0.01), reduced the number of proliferating cells, and inhibited interferon-gamma, IL-6, and IL-8 mRNA expression and nuclear factor-kappaB activation in injured arteries. In addition, in vitro data show that IL-18 affects smooth muscle cell proliferation.
CONCLUSIONS: These results identify a critical role for IL-18 in neointimal formation in a rat model of vascular injury and suggest a potential role for IL-18 neutralization in the reduction of neointimal development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16864728     DOI: 10.1161/CIRCULATIONAHA.105.602714

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  14 in total

1.  Effects of interleukin-18 on cardiac fibroblast function and gene expression.

Authors:  Charity Fix; Kellie Bingham; Wayne Carver
Journal:  Cytokine       Date:  2010-11-02       Impact factor: 3.861

2.  Macrophage-derived IL-18 and increased fibrinogen deposition are age-related inflammatory signatures of vascular remodeling.

Authors:  Luis Rodriguez-Menocal; Mohd Hafeez Faridi; Laisel Martinez; Lina A Shehadeh; Juan C Duque; Yuntao Wei; Annia Mesa; Angela Pena; Vineet Gupta; Si M Pham; Roberto I Vazquez-Padron
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-10       Impact factor: 4.733

3.  Proteomic identification of biomarkers of vascular injury.

Authors:  Ngan F Huang; Kyle Kurpinski; Qizhi Fang; Randall J Lee; Song Li
Journal:  Am J Transl Res       Date:  2010-11-21       Impact factor: 4.060

4.  Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18.

Authors:  Anthony J Valente; Tadashi Yoshida; Subramanyam N Murthy; Siva S V P Sakamuri; Masato Katsuyama; Robert A Clark; Patrice Delafontaine; Bysani Chandrasekar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-05-25       Impact factor: 4.733

5.  Interleukin-18/WNT1-inducible signaling pathway protein-1 signaling mediates human saphenous vein smooth muscle cell proliferation.

Authors:  Venkatapuram Seenu Reddy; Anthony J Valente; Patrice Delafontaine; Bysani Chandrasekar
Journal:  J Cell Physiol       Date:  2011-12       Impact factor: 6.384

6.  The anti-inflammatory agent bindarit inhibits neointima formation in both rats and hyperlipidaemic mice.

Authors:  Gianluca Grassia; Marcella Maddaluno; Angelo Guglielmotti; Giorgina Mangano; Giuseppe Biondi; Pasquale Maffia; Armando Ialenti
Journal:  Cardiovasc Res       Date:  2009-07-10       Impact factor: 10.787

7.  Plasma levels of interleukin 18, interleukin 10, and matrix metalloproteinase-9 and -137G/C polymorphism of interleukin 18 are associated with incidence of in-stent restenosis after percutaneous coronary intervention.

Authors:  Wenwei Liu; Yongsheng Liu; Hua Jiang; Xiangwu Ding; Rui Zhu; Bin Li; Yuqin Zhao
Journal:  Inflammation       Date:  2013-10       Impact factor: 4.092

8.  Exercise training decreases the size and alters the composition of the neointima in a porcine model of percutaneous transluminal coronary angioplasty (PTCA).

Authors:  Bradley S Fleenor; Douglas K Bowles
Journal:  J Appl Physiol (1985)       Date:  2009-06-25

9.  Bindarit inhibits human coronary artery smooth muscle cell proliferation, migration and phenotypic switching.

Authors:  Marcella Maddaluno; Gianluca Grassia; Maria Vittoria Di Lauro; Antonio Parisi; Francesco Maione; Carla Cicala; Daniele De Filippis; Teresa Iuvone; Angelo Guglielmotti; Pasquale Maffia; Nicola Mascolo; Armando Ialenti
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

10.  IL-10 Accelerates Re-Endothelialization and Inhibits Post-Injury Intimal Hyperplasia following Carotid Artery Denudation.

Authors:  Suresh K Verma; Venkata Naga Srikanth Garikipati; Prasanna Krishnamurthy; Mohsin Khan; Tina Thorne; Gangjian Qin; Douglas W Losordo; Raj Kishore
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.